Doxylin 50% WSP Greece - English - HMA (Heads of Medicines Agencies)

doxylin 50% wsp

dopharma research b. v. - doxycycline hyclate 500 mg/g - powder for oral solution - cattle, chicken, pigs - doxycycline

Doxylin 50% WSP Hungary - English - HMA (Heads of Medicines Agencies)

doxylin 50% wsp

dopharma research b. v. - doxycycline hyclate 500 mg/g - powder for oral solution - cattle, chicken, pigs - doxycycline

Doxylin 50% WSP Netherlands - English - HMA (Heads of Medicines Agencies)

doxylin 50% wsp

dopharma research b. v. - doxycycline hyclate 500 mg/g - powder for oral solution - cattle, chicken, pigs - doxycycline

Doxylin 50% WSP Portugal - English - HMA (Heads of Medicines Agencies)

doxylin 50% wsp

dopharma research b. v. - doxycycline hyclate 500 mg/g - powder for oral solution - cattle, chicken, pigs - doxycycline

Doxylin 50% WSP Romania - English - HMA (Heads of Medicines Agencies)

doxylin 50% wsp

dopharma research b. v. - doxycycline hyclate 500 mg/g - powder for oral solution - cattle, chicken, pigs - doxycycline

DOXYLIN 50 doxycycline 50mg (as hyclate) tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

doxylin 50 doxycycline 50mg (as hyclate) tablet blister pack

alphapharm pty ltd - doxycycline hyclate, quantity: 57.5 mg (equivalent: doxycycline, qty 50 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; sunset yellow fcf; quinoline yellow; macrogol 4000 - note: the 50mg tablet is not a paediatric formulation. doxycycline is indicated in the treatment of infections caused by the following microorganisms: mycoplasma pneumoniae: primary atypical pneumonia; rickettsiae: queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus; chlamydia psittaci: psittacosis; calymmatobacterium (donovania) granulomatis: granuloma inguinale; chlamydia trachomatis: lymphogranuloma venereum, trachoma, inclusion conjunctivitis (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone or in combination with topical agents.); doxycycline is indicated in the treatment of infections caused by the following gram-negative microorganisms: vibrio species: cholera; brucella species: brucellosis (in conjunction with streptomycin); yersinia pestis: plague; francisella tularensis

Doxylin 50 % WSP 500 mg/g or. sol. (pwdr.) jar Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

doxylin 50 % wsp 500 mg/g or. sol. (pwdr.) jar

dopharma (research) n.v. - doxycycline hyclate 500 mg/g - eq. doxycycline 433 mg/g - powder for oral solution - 500 mg/g - doxycycline hyclate 500 mg/g - doxycycline - poultry; cattle; pig

Doxylin 50 % WSP 500 mg/g or. sol. (pwdr.) jar Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

doxylin 50 % wsp 500 mg/g or. sol. (pwdr.) jar

dopharma (research) n.v. - doxycycline hyclate 500 mg/g - eq. doxycycline 433 mg/g - powder for oral solution - doxycycline